Trials / Completed
CompletedNCT04013568
Exercise Post-Diagnosis of Breast Cancer
A Pilot Study: The Effect of Longitudinal Exercise Programming in Breast Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- University of Hawaii · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are doing this study to determine if there are body composition changes after a 12-week exercise program in breast cancer patients and determine what factors contribute to sustained physical activity after the 12-week exercise program intervention.
Detailed description
The study is enrolling breast cancer patients up to 2 years after their diagnosis in a 12-week exercise program. The participants will either participate in: Group 1-participating in an exercise program with biometric evaluations or Group 2-biometric evaluations but not participating in the exercise program. At the end of the 12-week exercise program, participants in Group 1 will be randomized to either: a) continuing with exercise group classes or b) continuing with exercise individual classes. Both Group 1a and 1b participants will be followed for the remainder of the year and be evaluated for continued physical activity. All Group study participants' biometrics will be assessed at baseline and at the end of 12-weeks, with continued annual medical review follow-up for a total of 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise | First Intervention 12-week exercise program, 3 days/week, 90min exercise sessions at the Rehabilitation Hospital of the Pacific. Private or semi-private (1:1 or 2:1 ratio participant to instructor) sessions, led by Kinesiology students Second Intervention- 12-week exercise program, 2 days/week, 90min exercise sessions at the Rehabilitation Hospital of the Pacific. Group Fitness Classes |
Timeline
- Start date
- 2019-08-28
- Primary completion
- 2026-03-06
- Completion
- 2026-03-06
- First posted
- 2019-07-09
- Last updated
- 2026-03-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04013568. Inclusion in this directory is not an endorsement.